Similar articles for PMID: 17669208

Year	Number of Results
1988	1
1991	1
1992	1
1993	1
1994	2
1995	3
1996	1
2000	4
2001	5
2002	4
2003	7
2004	7
2005	18
2006	17
2007	21
2008	10
2009	6
2010	4
2011	5
2012	8
2013	1
2014	2
2015	3
2016	1
2017	1
2018	1
2019	2
2021	1
2024	0

1

Immunogenicity of a DNA prime and recombinant adenovirus boost regime significantly varies between rhesus macaques of Chinese and Indian origins.

Stahl-Hennig C, Suh YS, Park KS, Sauermann U, Kim KS, Ahn S, Franz M, Schulte R, Stolte-Leeb N, Hunsmann G, Sung YC. Stahl-Hennig C, et al. J Med Primatol. 2007 Aug;36(4-5):195-205. doi: 10.1111/j.1600-0684.2007.00237.x. J Med Primatol. 2007. PMID: 17669208

2

Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.

Suh YS, Park KS, Sauermann U, Franz M, Norley S, Wilfingseder D, Stoiber H, Fagrouch Z, Heeney J, Hunsmann G, Stahl-Hennig C, Sung YC. Suh YS, et al. Vaccine. 2006 Mar 10;24(11):1811-20. doi: 10.1016/j.vaccine.2005.10.026. Epub 2005 Oct 25. Vaccine. 2006. PMID: 16274888

3

Multiprotein genetic vaccine in the SIV-Macaca animal model: a promising approach to generate sterilizing immunity to HIV infection.

Maggiorella MT, Sernicola L, Crostarosa F, Belli R, Pavone-Cossut MR, Macchia I, Farcomeni S, Tenner-Racz K, Racz P, Ensoli B, Titti F. Maggiorella MT, et al. J Med Primatol. 2007 Aug;36(4-5):180-94. doi: 10.1111/j.1600-0684.2007.00236.x. J Med Primatol. 2007. PMID: 17669207

4

T-cell-mediated protective efficacy of a systemic vaccine approach in cynomolgus monkeys after SIV mucosal challenge.

Michelini Z, Negri DR, Baroncelli S, Catone S, Comini A, Maggiorella MT, Sernicola L, Crostarosa F, Belli R, Mancini MG, Farcomeni S, Fagrouch Z, Ciccozzi M, Rovetto C, Liljestrom P, Norley S, Heeney J, Titti F. Michelini Z, et al. J Med Primatol. 2004 Oct;33(5-6):251-61. doi: 10.1111/j.1600-0684.2004.00076.x. J Med Primatol. 2004. PMID: 15525326

5

Mucosal prior to systemic application of recombinant adenovirus boosting is more immunogenic than systemic application twice but confers similar protection against SIV-challenge in DNA vaccine-primed macaques.

Schulte R, Suh YS, Sauermann U, Ochieng W, Sopper S, Kim KS, Ahn SS, Park KS, Stolte-Leeb N, Hunsmann G, Sung YC, Stahl-Hennig C. Schulte R, et al. Virology. 2009 Jan 20;383(2):300-9. doi: 10.1016/j.virol.2008.10.012. Epub 2008 Nov 21. Virology. 2009. PMID: 19027133 Free article.

6

The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins.

Leung NJ, Aldovini A, Young R, Jarvis MA, Smith JM, Meyer D, Anderson DE, Carlos MP, Gardner MB, Torres JV. Leung NJ, et al. Virology. 2000 Mar 1;268(1):94-103. doi: 10.1006/viro.1999.0131. Virology. 2000. PMID: 10683331 Free article.

7

Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.

Martinon F, Brochard P, Ripaux M, Delache B, Aurégan G, Vaslin B, Le Grand R. Martinon F, et al. Vaccine. 2008 Jan 24;26(4):532-45. doi: 10.1016/j.vaccine.2007.11.025. Epub 2007 Dec 3. Vaccine. 2008. PMID: 18093703

8

Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.

McKenna PM, Koser ML, Carlson KR, Montefiori DC, Letvin NL, Papaneri AB, Pomerantz RJ, Dietzschold B, Silvera P, McGettigan JP, Schnell MJ. McKenna PM, et al. J Infect Dis. 2007 Apr 1;195(7):980-8. doi: 10.1086/512243. Epub 2007 Feb 20. J Infect Dis. 2007. PMID: 17330788

9

Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.

Kent SJ, Dale CJ, Ranasinghe C, Stratov I, De Rose R, Chea S, Montefiori DC, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Law M, Wilson KM, Ramsay AJ. Kent SJ, et al. Vaccine. 2005 Oct 10;23(42):5009-21. doi: 10.1016/j.vaccine.2005.05.032. Vaccine. 2005. PMID: 15985317

10

Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.

Suh YS, Park KS, Sauermann U, Kim KS, Ahn SS, Franz M, Schulte R, Wilfingseder D, Stoiber H, Uberla K, Hunsmann G, Stahl-Hennig C, Sung YC. Suh YS, et al. Vaccine. 2008 Dec 2;26(51):6690-8. doi: 10.1016/j.vaccine.2008.07.055. Vaccine. 2008. PMID: 18694796

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

125 results

Results by year